Arvinas Inc (ARVN)
33.16
+0.92
(+2.85%)
USD |
NASDAQ |
May 31, 16:00
33.14
-0.02
(-0.06%)
After-Hours: 20:00
Arvinas Cash from Operations (Quarterly): -97.50M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -97.50M |
| December 31, 2023 | -83.10M |
| September 30, 2023 | -84.80M |
| June 30, 2023 | -88.70M |
| March 31, 2023 | -91.20M |
| December 31, 2022 | -71.20M |
| September 30, 2022 | -66.60M |
| June 30, 2022 | -78.60M |
| March 31, 2022 | -57.10M |
| December 31, 2021 | -35.70M |
| September 30, 2021 | 681.50M |
| June 30, 2021 | -47.40M |
| March 31, 2021 | -39.00M |
| Date | Value |
|---|---|
| December 31, 2020 | -28.96M |
| September 30, 2020 | -22.38M |
| June 30, 2020 | -21.40M |
| March 31, 2020 | -16.95M |
| December 31, 2019 | -16.15M |
| September 30, 2019 | 1.854M |
| June 30, 2019 | -13.57M |
| March 31, 2019 | -12.73M |
| December 31, 2018 | -12.25M |
| September 30, 2018 | -10.99M |
| June 30, 2018 | -12.18M |
| March 31, 2018 | 19.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-97.50M
Minimum
Mar 2024
681.50M
Maximum
Sep 2021
-13.85M
Average
-43.20M
Median
Cash from Operations (Quarterly) Benchmarks
| Pfizer Inc | 1.09B |
| Bristol-Myers Squibb Co | 2.834B |
| Alnylam Pharmaceuticals Inc | -81.52M |
| Rhythm Pharmaceuticals Inc | -40.74M |
| IDEAYA Biosciences Inc | -43.81M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -127.80M |
| Cash from Financing (Quarterly) | 1.60M |
| Free Cash Flow | -356.00M |
| Free Cash Flow Per Share (Quarterly) | -1.361 |
| Free Cash Flow to Equity (Quarterly) | -97.50M |
| Free Cash Flow to Firm (Quarterly) | -97.60M |
| Free Cash Flow Yield | -17.86% |